

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.95077162 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91154062 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.81633883 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.81633883 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.74994425 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.70985212 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.61909809 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60723112 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60723112 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.43947209 |
| 11 | negative regulation of T cell mediated immunity (GO:0002710) | 4.38462413 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.33950049 |
| 13 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.02417002 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.00340121 |
| 15 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.00287048 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.94178974 |
| 17 | myeloid dendritic cell differentiation (GO:0043011) | 3.94022766 |
| 18 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.91410375 |
| 19 | positive regulation of B cell mediated immunity (GO:0002714) | 3.91410375 |
| 20 | cellular extravasation (GO:0045123) | 3.85669923 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84224929 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82844530 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.82056537 |
| 24 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.81359780 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81155504 |
| 26 | interferon-gamma production (GO:0032609) | 3.81079924 |
| 27 | regulation of chronic inflammatory response (GO:0002676) | 3.79943614 |
| 28 | myeloid dendritic cell activation (GO:0001773) | 3.79681302 |
| 29 | response to interleukin-15 (GO:0070672) | 3.78239093 |
| 30 | positive regulation of isotype switching (GO:0045830) | 3.73910670 |
| 31 | positive regulation of humoral immune response (GO:0002922) | 3.72386168 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.68296376 |
| 33 | leukocyte aggregation (GO:0070486) | 3.66947434 |
| 34 | regulation of immunoglobulin secretion (GO:0051023) | 3.64948060 |
| 35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.64481377 |
| 36 | positive regulation of interleukin-2 production (GO:0032743) | 3.60506902 |
| 37 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.60304512 |
| 38 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.60284078 |
| 39 | detection of bacterium (GO:0016045) | 3.58920330 |
| 40 | detection of other organism (GO:0098543) | 3.58410279 |
| 41 | T cell migration (GO:0072678) | 3.56410407 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 3.56176519 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.55764103 |
| 44 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.52673853 |
| 45 | defense response to protozoan (GO:0042832) | 3.51729662 |
| 46 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.50857783 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.50399951 |
| 48 | T cell selection (GO:0045058) | 3.45861590 |
| 49 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.45146005 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.42470353 |
| 51 | response to type I interferon (GO:0034340) | 3.41064668 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.39542110 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.39542110 |
| 54 | activated T cell proliferation (GO:0050798) | 3.39358793 |
| 55 | response to protozoan (GO:0001562) | 3.35323312 |
| 56 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.34642862 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.34642862 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.34229891 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 3.33619268 |
| 60 | germinal center formation (GO:0002467) | 3.33291323 |
| 61 | negative thymic T cell selection (GO:0045060) | 3.31892020 |
| 62 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.31632312 |
| 63 | negative T cell selection (GO:0043383) | 3.28938318 |
| 64 | positive regulation of activated T cell proliferation (GO:0042104) | 3.28642488 |
| 65 | positive thymic T cell selection (GO:0045059) | 3.27872490 |
| 66 | response to muramyl dipeptide (GO:0032495) | 3.27796339 |
| 67 | positive regulation of DNA recombination (GO:0045911) | 3.27624997 |
| 68 | tolerance induction (GO:0002507) | 3.25910696 |
| 69 | positive T cell selection (GO:0043368) | 3.23855011 |
| 70 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.23169693 |
| 71 | Peyers patch development (GO:0048541) | 3.23169693 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.22793342 |
| 73 | positive regulation of interferon-alpha production (GO:0032727) | 3.22725374 |
| 74 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.22674042 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22656557 |
| 76 | response to peptidoglycan (GO:0032494) | 3.20583269 |
| 77 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.19974174 |
| 78 | regulation of B cell differentiation (GO:0045577) | 3.18282553 |
| 79 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.17411274 |
| 80 | immunoglobulin mediated immune response (GO:0016064) | 3.16816108 |
| 81 | regulation of tolerance induction (GO:0002643) | 3.16166426 |
| 82 | positive regulation of interleukin-12 production (GO:0032735) | 3.16087066 |
| 83 | regulation of T-helper 1 type immune response (GO:0002825) | 3.13899793 |
| 84 | regulation of T-helper cell differentiation (GO:0045622) | 3.10948269 |
| 85 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.08876362 |
| 86 | regulation of natural killer cell differentiation (GO:0032823) | 3.08600885 |
| 87 | T cell homeostasis (GO:0043029) | 3.08594423 |
| 88 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08556801 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.06336031 |
| 90 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.06233623 |
| 91 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.06006884 |
| 92 | T-helper cell differentiation (GO:0042093) | 3.06006884 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 3.05037602 |
| 94 | regulation of B cell mediated immunity (GO:0002712) | 3.04849282 |
| 95 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.03657749 |
| 96 | lymphocyte chemotaxis (GO:0048247) | 3.03469623 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.01936136 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.01936136 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 3.01894227 |
| 100 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.99344748 |
| 101 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98516923 |
| 102 | regulation of response to interferon-gamma (GO:0060330) | 2.97912573 |
| 103 | positive regulation of type 2 immune response (GO:0002830) | 2.97339499 |
| 104 | positive regulation of interleukin-17 production (GO:0032740) | 2.97259448 |
| 105 | positive regulation of macrophage differentiation (GO:0045651) | 2.96951816 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.96001311 |
| 107 | leukocyte degranulation (GO:0043299) | 2.93883533 |
| 108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93510794 |
| 109 | regulation of granulocyte differentiation (GO:0030852) | 2.92363710 |
| 110 | negative regulation of adaptive immune response (GO:0002820) | 2.92343123 |
| 111 | regulation of interleukin-12 production (GO:0032655) | 2.91468728 |
| 112 | regulation of interleukin-2 production (GO:0032663) | 2.90241054 |
| 113 | regulation of chemokine biosynthetic process (GO:0045073) | 2.89685846 |
| 114 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89440049 |
| 115 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.88620491 |
| 116 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88578482 |
| 117 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88572708 |
| 118 | regulation of isotype switching (GO:0045191) | 2.86304033 |
| 119 | thymic T cell selection (GO:0045061) | 2.86291103 |
| 120 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86186056 |
| 121 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85912302 |
| 122 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.85679256 |
| 123 | positive regulation of immunoglobulin production (GO:0002639) | 2.85203618 |
| 124 | dendritic cell differentiation (GO:0097028) | 2.85136939 |
| 125 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.84865794 |
| 126 | detection of external biotic stimulus (GO:0098581) | 2.84731663 |
| 127 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.84103706 |
| 128 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.83191838 |
| 129 | growth hormone receptor signaling pathway (GO:0060396) | 2.82911465 |
| 130 | negative regulation of type 2 immune response (GO:0002829) | 2.82408651 |
| 131 | cellular response to interferon-beta (GO:0035458) | 2.81453086 |
| 132 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.80199871 |
| 133 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.79955452 |
| 134 | regulation of type 2 immune response (GO:0002828) | 2.79467225 |
| 135 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.78585155 |
| 136 | T cell differentiation involved in immune response (GO:0002292) | 2.78292430 |
| 137 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.78292430 |
| 138 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.78292430 |
| 139 | regulation of hypersensitivity (GO:0002883) | 2.76096618 |
| 140 | natural killer cell activation (GO:0030101) | 2.76080687 |
| 141 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75433566 |
| 142 | modulation by symbiont of host defense response (GO:0052031) | 2.75433566 |
| 143 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75433566 |
| 144 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75433566 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75433566 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.75433566 |
| 147 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.75355162 |
| 148 | positive regulation of interferon-gamma production (GO:0032729) | 2.75286834 |
| 149 | granulocyte activation (GO:0036230) | 2.74340284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.52851218 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.38505587 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.71212050 |
| 4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.62694042 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.03290213 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01884974 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.69120732 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.14397624 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.13942695 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12035869 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.94549238 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82503682 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73683180 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72897723 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65833545 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59255625 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54072350 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43331879 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40271749 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.33067191 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.31771827 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21942895 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.19213467 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.17265947 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14944618 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08452090 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.00856412 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 1.89636448 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87176937 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85670764 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84050522 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.82154545 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.76348468 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72970877 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71428007 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68168057 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66045610 |
| 38 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.63529683 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61083929 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.58448939 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57512991 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56558287 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53840140 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.50930615 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42018640 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41403320 |
| 47 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39979567 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39377500 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38258594 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37643735 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35196160 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34332021 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33887165 |
| 54 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33630330 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.33595205 |
| 56 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32700572 |
| 57 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32462566 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31883781 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31467985 |
| 60 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31147392 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31114152 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31048117 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27245339 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26460191 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25681577 |
| 66 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23868905 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21742363 |
| 68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20047705 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19730770 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14306152 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13581864 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13491393 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12544812 |
| 74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09301277 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08560310 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06935551 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06157016 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06131499 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05131719 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04505045 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04493758 |
| 82 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04043321 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03674205 |
| 84 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03059230 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02297386 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00263817 |
| 87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00114051 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99456063 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97476787 |
| 90 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96358047 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96140343 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95741470 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95334800 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94891575 |
| 95 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94202574 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92852827 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91358127 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91145654 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90950384 |
| 100 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90142003 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90059788 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88595350 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87947934 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87224742 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85675645 |
| 106 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85675645 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83931934 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83763199 |
| 109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83721013 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80518885 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78116359 |
| 112 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.77637736 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77096307 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75626699 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74767897 |
| 116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73883948 |
| 117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.73596482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.20441913 |
| 2 | MP0009785_altered_susceptibility_to | 3.68179700 |
| 3 | MP0003436_decreased_susceptibility_to | 3.64485049 |
| 4 | MP0005671_abnormal_response_to | 3.61542678 |
| 5 | MP0000685_abnormal_immune_system | 3.29160156 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.05247790 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.94057034 |
| 8 | MP0003303_peritoneal_inflammation | 2.84985170 |
| 9 | MP0005025_abnormal_response_to | 2.84145389 |
| 10 | MP0006082_CNS_inflammation | 2.82399793 |
| 11 | MP0004510_myositis | 2.80667751 |
| 12 | MP0001790_abnormal_immune_system | 2.78176795 |
| 13 | MP0005387_immune_system_phenotype | 2.78176795 |
| 14 | MP0003724_increased_susceptibility_to | 2.76365551 |
| 15 | MP0001853_heart_inflammation | 2.74777388 |
| 16 | MP0001800_abnormal_humoral_immune | 2.57943012 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.46426206 |
| 18 | MP0002723_abnormal_immune_serum | 2.46094198 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.36759936 |
| 20 | MP0002419_abnormal_innate_immunity | 2.36392064 |
| 21 | MP0002405_respiratory_system_inflammati | 2.24874918 |
| 22 | MP0001819_abnormal_immune_cell | 2.19049728 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.17284367 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.09395155 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.08003824 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.01448765 |
| 27 | MP0004947_skin_inflammation | 2.00192805 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.83932694 |
| 29 | MP0009764_decreased_sensitivity_to | 1.82788664 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.82610983 |
| 31 | MP0002398_abnormal_bone_marrow | 1.82031258 |
| 32 | MP0003866_abnormal_defecation | 1.74707142 |
| 33 | MP0000716_abnormal_immune_system | 1.73471993 |
| 34 | MP0002006_tumorigenesis | 1.73158317 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.60546212 |
| 36 | MP0003448_altered_tumor_morphology | 1.56794514 |
| 37 | MP0005310_abnormal_salivary_gland | 1.54107736 |
| 38 | MP0008469_abnormal_protein_level | 1.53265768 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.51655222 |
| 40 | MP0002722_abnormal_immune_system | 1.47972354 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.47174930 |
| 42 | MP0001873_stomach_inflammation | 1.46700932 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.44438398 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.44438398 |
| 45 | MP0002429_abnormal_blood_cell | 1.43150116 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.41846982 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.40794728 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.38729832 |
| 49 | MP0003828_pulmonary_edema | 1.35002827 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.30766365 |
| 51 | MP0000343_altered_response_to | 1.28925810 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.28535156 |
| 53 | MP0000858_altered_metastatic_potential | 1.24988999 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.17075593 |
| 55 | MP0002254_reproductive_system_inflammat | 1.16594043 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.13436530 |
| 57 | MP0008260_abnormal_autophagy | 1.13335164 |
| 58 | MP0009840_abnormal_foam_cell | 1.11942454 |
| 59 | MP0001348_abnormal_lacrimal_gland | 1.10095050 |
| 60 | MP0002933_joint_inflammation | 1.08237772 |
| 61 | MP0009763_increased_sensitivity_to | 1.07447533 |
| 62 | MP0005083_abnormal_biliary_tract | 1.01645099 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.98621515 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 0.95740626 |
| 65 | MP0001881_abnormal_mammary_gland | 0.95385317 |
| 66 | MP0001851_eye_inflammation | 0.94708170 |
| 67 | MP0003941_abnormal_skin_development | 0.93270189 |
| 68 | MP0009278_abnormal_bone_marrow | 0.92436380 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 0.92194452 |
| 70 | MP0005166_decreased_susceptibility_to | 0.91792596 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.90993987 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.88244917 |
| 73 | MP0000490_abnormal_crypts_of | 0.86929158 |
| 74 | MP0002396_abnormal_hematopoietic_system | 0.86683984 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.86538734 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 0.84757853 |
| 77 | MP0008004_abnormal_stomach_pH | 0.83495100 |
| 78 | MP0003186_abnormal_redox_activity | 0.82175061 |
| 79 | MP0002693_abnormal_pancreas_physiology | 0.81548829 |
| 80 | MP0005451_abnormal_body_composition | 0.81447309 |
| 81 | MP0003045_fibrosis | 0.80755960 |
| 82 | MP0000609_abnormal_liver_physiology | 0.79568183 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.79231104 |
| 84 | MP0003075_altered_response_to | 0.79170809 |
| 85 | MP0008057_abnormal_DNA_replication | 0.78965881 |
| 86 | MP0004381_abnormal_hair_follicle | 0.77430899 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.77393671 |
| 88 | MP0002132_abnormal_respiratory_system | 0.77209766 |
| 89 | MP0004084_abnormal_cardiac_muscle | 0.71967029 |
| 90 | MP0001216_abnormal_epidermal_layer | 0.71617712 |
| 91 | MP0005165_increased_susceptibility_to | 0.71229068 |
| 92 | MP0005390_skeleton_phenotype | 0.67622064 |
| 93 | MP0000604_amyloidosis | 0.67355559 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.67302202 |
| 95 | MP0000249_abnormal_blood_vessel | 0.67050991 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.65603515 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.65362418 |
| 98 | MP0004130_abnormal_muscle_cell | 0.63750749 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.63119327 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.63017795 |
| 101 | MP0003646_muscle_fatigue | 0.62285889 |
| 102 | MP0005023_abnormal_wound_healing | 0.61890891 |
| 103 | MP0009115_abnormal_fat_cell | 0.61720853 |
| 104 | MP0002139_abnormal_hepatobiliary_system | 0.61417113 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.61115293 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 0.60382000 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.60160884 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.60160884 |
| 109 | MP0003795_abnormal_bone_structure | 0.58111619 |
| 110 | MP0008995_early_reproductive_senescence | 0.57035041 |
| 111 | MP0001663_abnormal_digestive_system | 0.56850058 |
| 112 | MP0000313_abnormal_cell_death | 0.55504032 |
| 113 | MP0004883_abnormal_blood_vessel | 0.55475821 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.54514142 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.54244664 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.53839542 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52881270 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52633711 |
| 119 | MP0000598_abnormal_liver_morphology | 0.52467010 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.51537208 |
| 121 | MP0004147_increased_porphyrin_level | 0.50261536 |
| 122 | MP0008874_decreased_physiological_sensi | 0.50089334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.52831472 |
| 2 | Myositis (HP:0100614) | 4.88775711 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88410302 |
| 4 | Stomatitis (HP:0010280) | 4.87492111 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.69377636 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.52302579 |
| 7 | Optic neuritis (HP:0100653) | 4.52302579 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.52059747 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.46449930 |
| 10 | Orchitis (HP:0100796) | 4.42046251 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97515257 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.96292417 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.62297747 |
| 14 | Arterial thrombosis (HP:0004420) | 3.60342458 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59376490 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59376490 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.53735300 |
| 18 | Vasculitis (HP:0002633) | 3.53033342 |
| 19 | Recurrent skin infections (HP:0001581) | 3.50476302 |
| 20 | Interstitial pulmonary disease (HP:0006530) | 3.44376149 |
| 21 | Increased IgM level (HP:0003496) | 3.32399122 |
| 22 | Recurrent viral infections (HP:0004429) | 3.31299605 |
| 23 | Chronic otitis media (HP:0000389) | 3.26093688 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.19797906 |
| 25 | Thrombocytosis (HP:0001894) | 3.19732278 |
| 26 | Hemoptysis (HP:0002105) | 3.14966027 |
| 27 | T lymphocytopenia (HP:0005403) | 3.14021694 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.12724451 |
| 29 | Gingival bleeding (HP:0000225) | 3.09248409 |
| 30 | Abnormality of T cells (HP:0002843) | 3.07632168 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.07144975 |
| 32 | Keratoconjunctivitis (HP:0001096) | 3.06529892 |
| 33 | Granulocytopenia (HP:0001913) | 3.06310764 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.05680756 |
| 35 | Increased IgE level (HP:0003212) | 3.04955487 |
| 36 | Joint swelling (HP:0001386) | 3.00121427 |
| 37 | Obstructive lung disease (HP:0006536) | 2.95932807 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95932807 |
| 39 | Gingivitis (HP:0000230) | 2.90237100 |
| 40 | Nasal polyposis (HP:0100582) | 2.89873224 |
| 41 | Recurrent bronchitis (HP:0002837) | 2.89450721 |
| 42 | Petechiae (HP:0000967) | 2.88671682 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.85661505 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.84084726 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.83338305 |
| 46 | IgA deficiency (HP:0002720) | 2.82284402 |
| 47 | Meningitis (HP:0001287) | 2.82131920 |
| 48 | Pustule (HP:0200039) | 2.66842262 |
| 49 | Epistaxis (HP:0000421) | 2.65011197 |
| 50 | Microcytic anemia (HP:0001935) | 2.64186004 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.62094161 |
| 52 | Cellulitis (HP:0100658) | 2.58699998 |
| 53 | IgM deficiency (HP:0002850) | 2.57091387 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.57074091 |
| 55 | Hypochromic anemia (HP:0001931) | 2.56946958 |
| 56 | Increased serum ferritin (HP:0003281) | 2.53855020 |
| 57 | Chest pain (HP:0100749) | 2.52683075 |
| 58 | Chronic diarrhea (HP:0002028) | 2.50166743 |
| 59 | Gangrene (HP:0100758) | 2.46559180 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.45755120 |
| 61 | Cholecystitis (HP:0001082) | 2.45755120 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.44935121 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.43975715 |
| 64 | Urticaria (HP:0001025) | 2.43078970 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.42806742 |
| 66 | Anorexia (HP:0002039) | 2.42368861 |
| 67 | Eosinophilia (HP:0001880) | 2.41101175 |
| 68 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.40882817 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.38352261 |
| 70 | Pulmonary embolism (HP:0002204) | 2.38195496 |
| 71 | Leukocytosis (HP:0001974) | 2.37770024 |
| 72 | IgG deficiency (HP:0004315) | 2.34819167 |
| 73 | Polycythemia (HP:0001901) | 2.34094182 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.33238195 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.33186470 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.32255234 |
| 77 | Periodontitis (HP:0000704) | 2.30794844 |
| 78 | Hypertensive crisis (HP:0100735) | 2.30754279 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.29032005 |
| 80 | Encephalitis (HP:0002383) | 2.27982577 |
| 81 | Basal ganglia calcification (HP:0002135) | 2.27729203 |
| 82 | Acne (HP:0001061) | 2.26112058 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.25778978 |
| 84 | Inflammation of the large intestine (HP:0002037) | 2.23033126 |
| 85 | Colitis (HP:0002583) | 2.22615156 |
| 86 | Lymphopenia (HP:0001888) | 2.22594210 |
| 87 | Myocardial infarction (HP:0001658) | 2.21827540 |
| 88 | Esophageal varix (HP:0002040) | 2.21662667 |
| 89 | Thrombophlebitis (HP:0004418) | 2.21051209 |
| 90 | Keratitis (HP:0000491) | 2.17072386 |
| 91 | Cheilitis (HP:0100825) | 2.16347413 |
| 92 | Acute hepatic failure (HP:0006554) | 2.15423581 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15282134 |
| 94 | Severe combined immunodeficiency (HP:0004430) | 2.14375655 |
| 95 | Polyneuropathy (HP:0001271) | 2.12880489 |
| 96 | Slow saccadic eye movements (HP:0000514) | 2.11352482 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11213148 |
| 98 | Ventricular tachycardia (HP:0004756) | 2.09328578 |
| 99 | Episodic fever (HP:0001954) | 2.09161641 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.09061202 |
| 101 | Reticulocytosis (HP:0001923) | 2.06496110 |
| 102 | Abnormality of the pericardium (HP:0001697) | 2.05939829 |
| 103 | Fatigue (HP:0012378) | 2.02761797 |
| 104 | Abnormality of the endocardium (HP:0004306) | 2.02276582 |
| 105 | Arthralgia (HP:0002829) | 2.01435678 |
| 106 | Glomerulopathy (HP:0100820) | 2.00198098 |
| 107 | Skin ulcer (HP:0200042) | 2.00168629 |
| 108 | Purpura (HP:0000979) | 1.98842466 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.98798616 |
| 110 | Abnormal platelet function (HP:0011869) | 1.98798616 |
| 111 | Amaurosis fugax (HP:0100576) | 1.97813964 |
| 112 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96017235 |
| 113 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96017235 |
| 114 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96017235 |
| 115 | Combined immunodeficiency (HP:0005387) | 1.95863063 |
| 116 | Abnormality of the pleura (HP:0002103) | 1.94143631 |
| 117 | Tetraparesis (HP:0002273) | 1.92982272 |
| 118 | Osteomyelitis (HP:0002754) | 1.89835781 |
| 119 | Abnormality of the prostate (HP:0008775) | 1.88192909 |
| 120 | Vertigo (HP:0002321) | 1.85228190 |
| 121 | Abnormality of eosinophils (HP:0001879) | 1.85002077 |
| 122 | Menorrhagia (HP:0000132) | 1.84569522 |
| 123 | Systemic lupus erythematosus (HP:0002725) | 1.84302128 |
| 124 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.80479126 |
| 125 | Autoimmune hemolytic anemia (HP:0001890) | 1.80233720 |
| 126 | Nausea (HP:0002018) | 1.78856817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.27129143 |
| 2 | MAP4K1 | 4.06936490 |
| 3 | MAP3K14 | 3.42389270 |
| 4 | JAK3 | 3.39536822 |
| 5 | PRPF4B | 3.31876771 |
| 6 | TBK1 | 3.05384723 |
| 7 | TYK2 | 2.69108621 |
| 8 | IRAK3 | 2.64856365 |
| 9 | PIM2 | 2.52184392 |
| 10 | ZAP70 | 2.47035426 |
| 11 | IKBKB | 2.40055325 |
| 12 | IKBKE | 2.32023401 |
| 13 | FGFR4 | 2.29983247 |
| 14 | BLK | 2.25294713 |
| 15 | JAK1 | 2.06234497 |
| 16 | NME2 | 1.92428476 |
| 17 | IRAK4 | 1.91187348 |
| 18 | EPHA3 | 1.89134679 |
| 19 | BTK | 1.83757742 |
| 20 | TEC | 1.83353186 |
| 21 | CHUK | 1.82792621 |
| 22 | PBK | 1.78625720 |
| 23 | RIPK4 | 1.75038779 |
| 24 | MST4 | 1.73291141 |
| 25 | ITK | 1.72214982 |
| 26 | TRIB3 | 1.70009662 |
| 27 | EPHB1 | 1.65565410 |
| 28 | ERN1 | 1.57597310 |
| 29 | TNK2 | 1.52238203 |
| 30 | FGFR3 | 1.50742255 |
| 31 | PIM1 | 1.48011623 |
| 32 | NEK9 | 1.44295361 |
| 33 | SYK | 1.43335657 |
| 34 | NLK | 1.42226601 |
| 35 | PKN2 | 1.34433457 |
| 36 | SMG1 | 1.33664872 |
| 37 | TAOK3 | 1.33055946 |
| 38 | JAK2 | 1.32748558 |
| 39 | SIK3 | 1.32566996 |
| 40 | KSR2 | 1.24381699 |
| 41 | LCK | 1.21737391 |
| 42 | STK10 | 1.20043477 |
| 43 | KIT | 1.17169611 |
| 44 | HCK | 1.15384308 |
| 45 | MAP3K11 | 1.14063867 |
| 46 | MAP2K3 | 1.06871369 |
| 47 | CDK12 | 1.04031531 |
| 48 | MARK3 | 1.03024615 |
| 49 | IRAK1 | 0.98945361 |
| 50 | LRRK2 | 0.96030271 |
| 51 | STK24 | 0.95977339 |
| 52 | CSK | 0.95210898 |
| 53 | MATK | 0.92277949 |
| 54 | STK4 | 0.91864887 |
| 55 | EEF2K | 0.90397756 |
| 56 | FLT3 | 0.89563291 |
| 57 | RPS6KA4 | 0.88865375 |
| 58 | MAPK12 | 0.88750284 |
| 59 | TTN | 0.88662573 |
| 60 | MAP3K5 | 0.86144272 |
| 61 | MAPK11 | 0.85863561 |
| 62 | FGR | 0.81623870 |
| 63 | TIE1 | 0.79086791 |
| 64 | SIK1 | 0.78714987 |
| 65 | LYN | 0.78625984 |
| 66 | TGFBR2 | 0.75226724 |
| 67 | MAP3K8 | 0.72440347 |
| 68 | BMPR2 | 0.71829607 |
| 69 | RAF1 | 0.71571181 |
| 70 | MAP3K13 | 0.69266723 |
| 71 | MAP3K3 | 0.69058609 |
| 72 | EIF2AK1 | 0.68820208 |
| 73 | MAP2K6 | 0.67292900 |
| 74 | TESK2 | 0.67286246 |
| 75 | MAP3K12 | 0.64986153 |
| 76 | YES1 | 0.62717410 |
| 77 | TGFBR1 | 0.61573537 |
| 78 | RPS6KC1 | 0.60607624 |
| 79 | RPS6KL1 | 0.60607624 |
| 80 | RIPK1 | 0.57896086 |
| 81 | MAP3K1 | 0.57866291 |
| 82 | BMX | 0.57456464 |
| 83 | PTK6 | 0.55799849 |
| 84 | PRKCQ | 0.55509550 |
| 85 | TAOK1 | 0.54841202 |
| 86 | MYLK | 0.54035655 |
| 87 | ICK | 0.52443709 |
| 88 | KDR | 0.51586461 |
| 89 | MAPKAPK2 | 0.50890448 |
| 90 | TRPM7 | 0.50321354 |
| 91 | MAP3K2 | 0.50090817 |
| 92 | PDPK1 | 0.49630014 |
| 93 | MARK2 | 0.48018999 |
| 94 | ALK | 0.46851830 |
| 95 | SIK2 | 0.46343610 |
| 96 | MAP3K6 | 0.45711998 |
| 97 | RET | 0.44583727 |
| 98 | CSF1R | 0.42867668 |
| 99 | CDK6 | 0.42859020 |
| 100 | CAMKK1 | 0.40476158 |
| 101 | HIPK2 | 0.39770953 |
| 102 | CLK1 | 0.39228927 |
| 103 | CDC42BPA | 0.38573437 |
| 104 | MAP3K10 | 0.38417647 |
| 105 | ABL2 | 0.37018349 |
| 106 | PRKCD | 0.35737592 |
| 107 | CAMKK2 | 0.35589056 |
| 108 | MAPK3 | 0.34633254 |
| 109 | ABL1 | 0.33746038 |
| 110 | MST1R | 0.33114353 |
| 111 | MAP3K7 | 0.32679352 |
| 112 | FYN | 0.32320632 |
| 113 | MAPKAPK3 | 0.30364891 |
| 114 | PIK3CG | 0.30280376 |
| 115 | TAOK2 | 0.30189095 |
| 116 | DAPK3 | 0.29806794 |
| 117 | PDGFRB | 0.29133864 |
| 118 | PDK1 | 0.28680122 |
| 119 | DYRK1B | 0.28349275 |
| 120 | RPS6KA1 | 0.27966228 |
| 121 | RPS6KA5 | 0.27765139 |
| 122 | RPS6KA6 | 0.25453831 |
| 123 | GRK6 | 0.25049901 |
| 124 | FES | 0.24646577 |
| 125 | GRK7 | 0.24504186 |
| 126 | EIF2AK2 | 0.24313556 |
| 127 | TLK1 | 0.24182393 |
| 128 | PRKCH | 0.23626515 |
| 129 | CDK4 | 0.22937095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.73592787 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.72725806 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.36559410 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.15018342 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02560713 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.90752855 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71549675 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.64312878 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.58993058 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54017029 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43325159 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38499983 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34175358 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.15352169 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14295801 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14126694 |
| 17 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.14039643 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13476581 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02758112 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.86031739 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80817954 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77767592 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75460944 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70846515 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63203403 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61342175 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.60993507 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60765438 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.58710072 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.52039811 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.48657474 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48346220 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45386660 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37889552 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33450062 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26413236 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23666901 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22458812 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19935254 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18805131 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.17898764 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.12101278 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.08101441 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98113084 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97268048 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93909792 |
| 47 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90889171 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.89986020 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86929838 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.86826396 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80366179 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74588856 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.73736065 |
| 54 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72329560 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.66068086 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64272809 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63818081 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63614981 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63114207 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.61351651 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60970659 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58614050 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.54717911 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.53570727 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52193211 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50111124 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48683281 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46909145 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45029556 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43487540 |
| 71 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42536200 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42363249 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41952862 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41293994 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40900841 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38905822 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38177220 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37595217 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36903810 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36548046 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35734971 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.34500697 |
| 83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34317904 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33560140 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33141313 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31806944 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28932469 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28447363 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.28268009 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28119823 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.27759684 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27274340 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27189998 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27056459 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26395860 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26178881 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25627179 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24146397 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23254927 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23198375 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22986976 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21938336 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21929307 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21698490 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.21214034 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19835636 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19495536 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16272367 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.16110182 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14890155 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14867922 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.14321419 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.12536685 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.11546529 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10081475 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09471541 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09199098 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.08616744 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.08199542 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.03643723 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.03119365 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.02235158 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01850183 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.01390862 |

